Équilibre potassique, hypokaliémie et hyperkaliémie
- 1 June 2010
- journal article
- abstracts
- Published by JLE in Nephrologie & Therapeutique
- Vol. 6 (3) , 180-199
Abstract
Potassium (K+) is a key component of the resting membrane potential of all cells that influences many important biologic events. The clinical importance of K+ is that surpluses or deficits in K+ in the extracellular fluid may predispose the patient to cardiac arrhythmias. The kidneys adjust overall K+ homeostasis by increasing or decreasing the rate of excretion of K+. Urinary excretion of K+ has 2 components: (i) the concentration of K+ in the tubular fluid that depends on the capacity of the cortical collecting duct to secrete K+. The capacity is determined by the lumen-negative transepithelial potential difference generated by the electrogenic reabsorption of Na+. Aldosterone and to a lesser degree HCO3- and Na+ in the tubular fluid are implicated in the generation of the potential difference. This component is evaluated by the transtubular K+ gradient (TTKG). (ii) The volume of fluid delivered to the cortical collecting duct that depends on the osmolar rate of excretion. These 2 components can be calculated if blood osmolality is higher than urine osmolality. Thus, investigating K+ abnormalities is based on the determination of TTKG and osmolar rate of excretion in the cortical collecting duct, on other clinical (extracellular fluid, blood pressure...) and biological data (24-hour K+ excretion, renin, aldosterone...) easily available. First treatment of K+ abnormality is the treatment of its cause. Insulin and glucose supply and dialysis are the best symptomatic treatments of hyperkalaemia.Keywords
This publication has 48 references indexed in Scilit:
- Mineralocorticoid Hypertension and HypokalemiaSeminars in Nephrology, 2006
- Type 2 Pseudohypoaldosteronism: New Insights Into Renal Potassium, Sodium, and Chloride HandlingAmerican Journal of Kidney Diseases, 2006
- From bench to bedside: Diagnosis of Gitelman's syndrome – defect of sodium-chloride cotransporter in renal tissueKidney International, 2006
- Familial Hyperkalemic HypertensionJournal of the American Society of Nephrology, 2006
- Monogenic low renin hypertensionTrends in Endocrinology & Metabolism, 2005
- Hyperkalemia-induced ECG abnormalities in patients with reduced renal functionClinical Nephrology, 2004
- Bartter’s and Gitelman’s Syndromes: From Gene to ClinicNephron Physiology, 2004
- Mendelian Forms of Human Hypertension and Mechanisms of DiseaseClinical Medicine & Research, 2003
- Cyclosporin A inhibits apical secretory K+ channels in rabbit cortical collecting tubule principal cellsKidney International, 1993
- Renal Potassium Wasting in the Absence of AldosteroneNephron, 1993